Detalles de la búsqueda
1.
The Incorporation of Extracellular Vesicles from Mesenchymal Stromal Cells Into CD34+ Cells Increases Their Clonogenic Capacity and Bone Marrow Lodging Ability.
Stem Cells
; 37(10): 1357-1368, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31184411
2.
Deferasirox reduces oxidative DNA damage in bone marrow cells from myelodysplastic patients and improves their differentiation capacity.
Br J Haematol
; 187(1): 93-104, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31172513
3.
Azacitidine improves outcome in higher-risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries.
Br J Haematol
; 181(3): 350-359, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29611196
4.
Multidimensional assessment of patient condition and mutational analysis in peripheral blood, as tools to improve outcome prediction in myelodysplastic syndromes: A prospective study of the Spanish MDS group.
Am J Hematol
; 92(9): E534-E541, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28612357
5.
Insights into the human mesenchymal stromal/stem cell identity through integrative transcriptomic profiling.
BMC Genomics
; 17(1): 944, 2016 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27871224
6.
Effect of mTORC1/mTORC2 inhibition on T cell function: potential role in graft-versus-host disease control.
Br J Haematol
; 173(5): 754-68, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26914848
7.
Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
Cytotherapy
; 18(10): 1297-311, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27637760
8.
MSC surface markers (CD44, CD73, and CD90) can identify human MSC-derived extracellular vesicles by conventional flow cytometry.
Cell Commun Signal
; 14: 2, 2016 Jan 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26754424
9.
Immunomodulatory effects of bone marrow versus adipose tissue-derived mesenchymal stromal cells on NK cells: implications in the transplantation setting.
Eur J Haematol
; 97(6): 528-537, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27118602
10.
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.
Blood
; 122(17): 2943-64, 2013 Oct 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-23980065
11.
Transcriptomic portrait of human Mesenchymal Stromal/Stem Cells isolated from bone marrow and placenta.
BMC Genomics
; 15: 910, 2014 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-25326687
12.
Multivariate time-dependent comparison of the impact of lenalidomide in lower-risk myelodysplastic syndromes with chromosome 5q deletion.
Br J Haematol
; 166(2): 189-201, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24716538
13.
Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease.
Haematologica
; 99(7): 1168-75, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24727813
14.
Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study.
Eur J Haematol
; 93(5): 429-38, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24813620
15.
A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q.
Blood
; 118(14): 3765-76, 2011 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-21753188
16.
Uptake and delivery of antigens by mesenchymal stromal cells.
Cytotherapy
; 15(6): 673-8, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23522868
17.
Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome.
Cancer
; 118(1): 127-33, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21717439
18.
Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes.
Br J Haematol
; 159(3): 311-21, 2012 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22958186
19.
Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting.
Blood
; 115(1): 107-21, 2010 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-19887673
20.
The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation.
Haematologica
; 97(9): 1329-37, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22532520